{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:12:45Z","timestamp":1788372765166,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T00:00:00Z","timestamp":1705881600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The Nature Science Foundation of China","award":["Grant No. 81873513, 81600574, and 30871042"],"award-info":[{"award-number":["Grant No. 81873513, 81600574, and 30871042"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>Current guidelines are debated when it comes to starting anticoagulant therapy in patients with non-valvular atrial fibrillation (NVAF) and low CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc scores (1\u20132 in women and 0\u20131 in men).\u00a0However, these individuals still have a high\u00a0likelihood of developing left atrial thrombus\/spontaneous echo contrast (LAT\/SEC) and experiencing subsequent thromboembolism.\u00a0Recent research has demonstrated that lipoprotein(a) [Lp(a)] may increase the risk of thrombosis, but the relationship between Lp(a) and\u00a0LAT\/SEC\u00a0in NVAF\u00a0patients is not clearly established. Therefore, this study sought to evaluate\u00a0the predictive\u00a0ability\u00a0of Lp(a) for\u00a0LAT\/SEC\u00a0among\u00a0NVAF\u00a0patients\u00a0with\u00a0low CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>NVAF patients with available transesophageal echocardiography (TEE) data were evaluated. Based on the TEE results, the subjects were classified into non-LAT\/SEC and LAT\/SEC groups. The risk factors for LAT\/SEC were examined using binary logistic regression analyses and were validated by using 1:1 propensity score matching (PSM). Subsequently, novel predictive models for LAT\/SEC were developed by integrating the CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score with the identified factors, and the accuracy of these models was tested\u00a0using receiver operating characteristic (ROC) analysis.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In total, 481 NVAF patients were enrolled. The LAT\/SEC group displayed higher Lp(a) concentrations. It was found that enlarged left atrial diameter (LAD), high concentrations of Lp(a), and a history of coronary heart disease (CHD) were independent predictors of LAT\/SEC. Lp(a) and LAD still had predictive values for LAT\/SEC after adjusting for PSM. In both the highest quartile groups of Lp(a) (&gt;266 mg\/L) and LAD (&gt;39.5 mm), the occurrence of LAT\/SEC was higher than that in the corresponding lowest quartile. By incorporating Lp(a) and the LAD, the predictive value of the CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score for LAT\/SEC was significantly improved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Elevated Lp(a) and enlarged LAD were independent risk factors for LAT\/SEC among NVAF patients with low CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc scores. The prediction accuracy of the CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score for LAT\/SEC was significantly improved by the addition of Lp(a) and LAD. When evaluating the stroke risk in patients with NVAF, Lp(a) and LAD should be taken into account together with the CHA<jats:sub>2<\/jats:sub>DS<jats:sub>2<\/jats:sub>-VASc score.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial registration<\/jats:title>\n                <jats:p>Retrospectively registered.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01990-1","type":"journal-article","created":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T10:03:01Z","timestamp":1705917781000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Predictive value of lipoprotein(a) for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc scores: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Kamila","family":"Kamili","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaodi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,22]]},"reference":[{"key":"1990_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1136\/heartjnl-2019-314898","volume":"106","author":"S Jame","year":"2020","unstructured":"Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart. 2020;106:10\u20137.","journal-title":"Heart"},{"key":"1990_CR2","doi-asserted-by":"publisher","first-page":"e0191648","DOI":"10.1371\/journal.pone.0191648","volume":"13","author":"YG Kim","year":"2018","unstructured":"Kim YG, Choi J-I, Kim M-N, Cho D-H, Oh S-K, Kook H, Park H-S, Lee KN, Baek Y-S, Roh S-Y. Non-vitamin K antagonist oral anticoagulants versus warfarin for the prevention of spontaneous echo-contrast and thrombus in patients with atrial fibrillation or flutter undergoing cardioversion: a trans-esophageal echocardiography study. PLoS One. 2018;13:e0191648.","journal-title":"PLoS One"},{"key":"1990_CR3","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, Boriani G, Castella M, Dan G-A, Dilaveris PE. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42:373\u2013498.","journal-title":"Eur Heart J"},{"key":"1990_CR4","first-page":"735","volume":"48","author":"X-B Liu","year":"2020","unstructured":"Liu X-B, Jia Z-X, Xia S-J, He L, Lu S-X, Guo X-Y, Li S-N, Liu N, Jiang C-X, Sang C-H. The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics. Zhonghua xin xue Guan Bing za zhi. 2020;48:735\u20139.","journal-title":"Zhonghua xin xue Guan Bing za zhi"},{"key":"1990_CR5","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.jacc.2014.11.046","volume":"65","author":"T-F Chao","year":"2015","unstructured":"Chao T-F, Liu C-J, Wang K-L, Lin Y-J, Chang S-L, Lo L-W, Hu Y-F, Tuan T-C, Chen T-J, Lip GY. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation? J Am Coll Cardiol. 2015;65:635\u201342.","journal-title":"J Am Coll Cardiol"},{"key":"1990_CR6","doi-asserted-by":"crossref","unstructured":"Hayden DT, Hannon N, Callaly E, D NC, Horgan G, Kyne L, Duggan J, Dolan E, O'Rourke K, Williams D, et al: Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study. Stroke. 2015; 46:3488-3493.","DOI":"10.1161\/STROKEAHA.115.011139"},{"key":"1990_CR7","doi-asserted-by":"publisher","first-page":"105812","DOI":"10.1016\/j.phrs.2021.105812","volume":"173","author":"M Ruscica","year":"2021","unstructured":"Ruscica M, Sirtori CR, Corsini A, Watts GF, Sahebkar A. Lipoprotein (a): Knowns, unknowns and uncertainties. Pharmacol Res. 2021;173:105812.","journal-title":"Pharmacol Res"},{"key":"1990_CR8","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s12944-022-01682-2","volume":"21","author":"J Song","year":"2022","unstructured":"Song J, Zhang X, Wei M, Bo Y, Zhou X, Tang B. Association between lipoprotein (a) and thromboembolism in patients with non-valvular atrial fibrillation: a cross-sectional study. Lipids Health Dis. 2022;21:78.","journal-title":"Lipids Health Dis"},{"key":"1990_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1253\/jcj.64.93","volume":"64","author":"Y Igarashi","year":"2000","unstructured":"Igarashi Y, Kasai H, Yamashita F, Sato T, Inuzuka H, Ojima K, Aizawa Y. Lipoprotein (a), left atrial appendage function and thromboembolic risk in patients with chronic nonvalvular atrial fibrillation. Japan Circ J. 2000;64:93\u20138.","journal-title":"Japan Circ J"},{"key":"1990_CR10","first-page":"63","volume":"8","author":"V Koca","year":"1999","unstructured":"Koca V, Bozat T, Akkaya V, Sarikamis C, Turk T, Vural H, Ozdemir A. Left atrial thrombus detection with multiplane transesophageal echocardiography: an echocardiographic study with surgical verification. J Heart Valve Dis. 1999;8:63\u20136.","journal-title":"J Heart Valve Dis"},{"key":"1990_CR11","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/0735-1097(91)90592-W","volume":"18","author":"IW Black","year":"1991","unstructured":"Black IW, Hopkins AP, Lee LC, Walsh WF. Left atrial spontaneous echo contrast: a clinical and echocardiographic analysis. J Am Coll Cardiol. 1991;18:398\u2013404.","journal-title":"J Am Coll Cardiol"},{"key":"1990_CR12","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1160\/th15-07-0532","volume":"115","author":"MND Di Minno","year":"2016","unstructured":"Di Minno MND, Ambrosino P, Russo AD, Casella M, Tremoli E, Tondo C. Prevalence of left atrial thrombus in patients with non-valvular atrial fibrillation. Thromb Haemost. 2016;115:663\u201377.","journal-title":"Thromb Haemost"},{"key":"1990_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/S0735-1097(19)31025-3","volume":"73","author":"H Whiteside","year":"2019","unstructured":"Whiteside H, Nagabandi A, Brown K, Ayyala DN, Sharma G. Prevalence and clinical characteristics associated with left atrial thrombus detection: Apixaban. J Am Coll Cardiol. 2019;73:417\u2013417.","journal-title":"J Am Coll Cardiol"},{"key":"1990_CR14","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1007\/s11239-021-02554-9","volume":"53","author":"J Chen","year":"2022","unstructured":"Chen J, Zhou M, Wang H, Zheng Z, Rong W, He B, Zhao L. Risk factors for left atrial thrombus or spontaneous echo contrast in non-valvular atrial fibrillation patients with low CHA2DS2-VASc score. J Thromb Thromb. 2022;53:523\u201331.","journal-title":"J Thromb Thromb"},{"key":"1990_CR15","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1136\/heartjnl-2020-317612","volume":"107","author":"A Almorad","year":"2021","unstructured":"Almorad A, Ohanyan A, Bentea GP, Wielandts J-Y, El Haddad M, Lycke M, O\u2019Neill L, Morissens M, De Keyzer E, Nguyen T. D-dimer blood concentrations to exclude left atrial thrombus in patients with atrial fibrillation. Heart. 2021;107:195\u2013200.","journal-title":"Heart"},{"key":"1990_CR16","doi-asserted-by":"publisher","first-page":"e67","DOI":"10.1161\/CIR.0000000000000558","volume":"137","author":"EJ Benjamin","year":"2018","unstructured":"Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, et al. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018;137:e67\u2013492.","journal-title":"Circulation"},{"key":"1990_CR17","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.cjca.2017.12.008","volume":"34","author":"Y Zhan","year":"2018","unstructured":"Zhan Y, Joza J, Al Rawahi M, Barbosa RS, Samuel M, Bernier M, Huynh T, Thanassoulis G, Essebag V. Assessment and management of the left atrial appendage thrombus in patients with nonvalvular atrial fibrillation. Can J Cardiol. 2018;34:252\u201361.","journal-title":"Can J Cardiol"},{"key":"1990_CR18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1016\/j.jacc.2015.01.044","volume":"65","author":"GY Lip","year":"2015","unstructured":"Lip GY, Skj\u00f8th F, Rasmussen LH, Larsen TB. Oral anticoagulation, aspirin, or no therapy in patients with nonvalvular AF with 0 or 1 stroke risk factor based on the CHA2DS2-VASc score. J Am Coll Cardiol. 2015;65:1385\u201394.","journal-title":"J Am Coll Cardiol"},{"key":"1990_CR19","doi-asserted-by":"publisher","first-page":"2529","DOI":"10.3390\/jcm12072529","volume":"12","author":"SA Di Fusco","year":"2023","unstructured":"Di Fusco SA, Maggioni AP, Scicchitano P, Zuin M, D\u2019Elia E, Colivicchi F. Lipoprotein (a), Inflammation, and Atherosclerosis. J Clin Med. 2023;12:2529.","journal-title":"J Clin Med"},{"key":"1990_CR20","doi-asserted-by":"crossref","unstructured":"Duarte Lau F, Giugliano RP. Lipoprotein(a) and its significance in cardiovascular disease: A review. JAMA Cardiology. 2022;7:760\u20139.","DOI":"10.1001\/jamacardio.2022.0987"},{"key":"1990_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1136\/heartjnl-2021-320708","volume":"109","author":"SA Di Fusco","year":"2023","unstructured":"Di Fusco SA, Arca M, Scicchitano P, Alonzo A, Perone F, Gulizia MM, Gabrielli D, Oliva F, Imperoli G, Colivicchi F. Lipoprotein (a): a risk factor for atherosclerosis and an emerging therapeutic target. Heart. 2023;109:18\u201325.","journal-title":"Heart"},{"key":"1990_CR22","doi-asserted-by":"crossref","unstructured":"Jawi MM, Frohlich J, Chan SY. Lipoprotein(a) the insurgent: A new insight into the structure, function, metabolism, pathogenicity, and medications affecting lipoprotein(a) molecule. J Lipids. 2020;2020:3491764.","DOI":"10.1155\/2020\/3491764"},{"key":"1990_CR23","doi-asserted-by":"publisher","first-page":"839","DOI":"10.2174\/092986607782110202","volume":"14","author":"D Barre","year":"2007","unstructured":"Barre D. The molecular nature and consequences of lipoprotein (a)\u2019s association with platelets. Protein Peptide Lett. 2007;14:839\u201342.","journal-title":"Protein Peptide Lett"},{"key":"1990_CR24","doi-asserted-by":"crossref","unstructured":"Jang AY, Han SH, Sohn IS, Oh PC, Koh KK. Lipoprotein(a) and cardiovascular diseases - revisited. Circ J 2020;84:867\u201374.","DOI":"10.1253\/circj.CJ-20-0051"},{"key":"1990_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2298\/MPNS0702037V","volume":"60","author":"B Vu\u010dkovi\u0107","year":"2007","unstructured":"Vu\u010dkovi\u0107 B, \u0110eri\u0107 M. Lipoprotein (a): a link between thrombogenesis and atherogenesis. Medicinski Pregled. 2007;60:37\u201341.","journal-title":"Medicinski Pregled"},{"key":"1990_CR26","doi-asserted-by":"publisher","first-page":"2980","DOI":"10.1182\/blood.V98.10.2980","volume":"98","author":"NM Caplice","year":"2001","unstructured":"Caplice NM, Panetta C, Peterson TE, Kleppe LS, Mueske CS, Kostner GM, Broze GJ Jr, Simari RD. Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis. Blood. 2001;98:2980\u20137.","journal-title":"Blood"},{"key":"1990_CR27","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.jacl.2019.04.010","volume":"13","author":"DP Wilson","year":"2019","unstructured":"Wilson DP, Jacobson TA, Jones PH, Koschinsky ML, McNeal CJ, Nordestgaard BG, Orringer CE. Use of lipoprotein (a) in clinical practice: a biomarker whose time has come. A scientific statement from the National Lipid Association. J Clin Lipidol. 2019;13:374\u201392.","journal-title":"J Clin Lipidol."},{"key":"1990_CR28","doi-asserted-by":"publisher","first-page":"2390","DOI":"10.1093\/hmg\/ddu731","volume":"24","author":"W Lu","year":"2015","unstructured":"Lu W, Cheng Y-C, Chen K, Wang H, Gerhard GS, Still CD, Chu X, Yang R, Parihar A, O\u2019Connell JR. Evidence for several independent genetic variants affecting lipoprotein (a) cholesterol levels. Hum Mol Genet. 2015;24:2390\u2013400.","journal-title":"Hum Mol Genet"},{"key":"1990_CR29","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ijcard.2015.02.109","volume":"184","author":"E Zhang","year":"2015","unstructured":"Zhang E, Liu T, Li Z, Zhao J, Li G. High CHA2DS2\u2212 VASc score predicts left atrial thrombus or spontaneous echo contrast detected by transesophageal echocardiography. Int J Cardiol. 2015;184:540\u20132.","journal-title":"Int J Cardiol"},{"key":"1990_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/CLEP.S47385","volume":"6","author":"M Zoni-Berisso","year":"2014","unstructured":"Zoni-Berisso M, Lercari F, Carazza T, Domenicucci S. Epidemiology of atrial fibrillation: European perspective. Clinical epidemiology. 2014;6:213.","journal-title":"Clinical epidemiology"},{"key":"1990_CR31","first-page":"33","volume":"1","author":"AMA Al Missary","year":"2011","unstructured":"Al Missary AMA. Echocardiographic Predictors of Non Rheumatic Atrial Fibrillation. Diyala J Med. 2011;1:33\u20136.","journal-title":"Diyala J Med"},{"key":"1990_CR32","doi-asserted-by":"publisher","first-page":"183","DOI":"10.2188\/jea.JE20180251","volume":"30","author":"A Higashiyama","year":"2020","unstructured":"Higashiyama A, Kokubo Y, Watanabe M, Nakao YM, Okamura T, Okayama A, Miyamoto Y. Echocardiographic parameters and the risk of incident atrial fibrillation: the Suita study. J Epidemiol. 2020;30:183\u20137.","journal-title":"J Epidemiol"},{"key":"1990_CR33","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1016\/j.jacc.2021.04.012","volume":"77","author":"YC Chen","year":"2021","unstructured":"Chen YC, Voskoboinik A, La Gerche A, Marwick TH, McMullen JR. Prevention of pathological atrial remodeling and atrial fibrillation: JACC state-of-the-art review. J Am Coll Cardiol. 2021;77:2846\u201364.","journal-title":"J Am Coll Cardiol"},{"key":"1990_CR34","first-page":"155","volume":"17","author":"W-D Lin","year":"2020","unstructured":"Lin W-D, Xue Y-M, Liu F-Z, Fang X-H, Zhan X-Z, Liao H-T, Tse G, Wu S-L. Left atrial enlargement and non-paroxysmal atrial fibrillation as risk factors for left atrial thrombus\/spontaneous Echo contrast in patients with atrial fibrillation and low CHA2DS2-VASc score. J Geriatr Cardiol. 2020;17:155.","journal-title":"J Geriatr Cardiol"},{"key":"1990_CR35","unstructured":"Zhou M, Chen J, Wang H, Xi S, Gan T, Zhao L: Independent risk factors of atrial thrombosis in patients with nonvalvular atrial fibrillation and low CHA 2 DS 2-VASc scores. Nan Fang yi ke da xue xue bao= Journal of Southern Medical University. 2021; 41:1243-1249."},{"key":"1990_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31042","volume":"6","author":"Y Hamatani","year":"2016","unstructured":"Hamatani Y, Ogawa H, Takabayashi K, Yamashita Y, Takagi D, Esato M, Chun Y-H, Tsuji H, Wada H, Hasegawa K. Left atrial enlargement is an independent predictor of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Sci Rep. 2016;6:1\u20138.","journal-title":"Sci Rep"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01990-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01990-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01990-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,22]],"date-time":"2024-01-22T10:08:07Z","timestamp":1705918087000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01990-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,22]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1990"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01990-1","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,22]]},"assertion":[{"value":"26 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was conducted according to the principles expressed in the Declaration of Helsinki. The Research Ethics Committee of the First Affiliated Hospital of Xi'an Jiaotong University was consulted, and the need for informed consent was waived due to the observational nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}